Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Baxter
Cantor Fitzgerald
Boehringer Ingelheim
Julphar
McKinsey
Merck
Chubb

Generated: July 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: enoxaparin sodium

« Back to Dashboard

enoxaparin sodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0620-40
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0621-60
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0622-80
Sanofi Aventis Us LOVENOX enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 020164 NDA sanofi-aventis U.S. LLC N 0075-0623-00
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Moodys
Deloitte
Farmers Insurance
Express Scripts
Citi
US Army
Julphar